BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21093481)

  • 1. Blood lead levels in relation to cognitive function in older U.S. adults.
    van Wijngaarden E; Winters PC; Cory-Slechta DA
    Neurotoxicology; 2011 Jan; 32(1):110-5. PubMed ID: 21093481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microalbuminuria is a negative correlate for cognitive function in older adults with peripheral arterial disease: results from the U.S. National Health and Nutrition Examination Survey 1999-2002.
    Kuo HK; Lin LY; Yu YH
    J Intern Med; 2007 Nov; 262(5):562-70. PubMed ID: 17949365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of low-level blood lead and blood pressure in NHANES 1999-2006.
    Scinicariello F; Abadin HG; Murray HE
    Environ Res; 2011 Nov; 111(8):1249-57. PubMed ID: 21907978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood lead levels--United States, 1999-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 May; 54(20):513-6. PubMed ID: 15917736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys.
    Muntner P; Menke A; DeSalvo KB; Rabito FA; Batuman V
    Arch Intern Med; 2005 Oct; 165(18):2155-61. PubMed ID: 16217007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active and passive smoking and blood lead levels in U.S. adults: data from the Third National Health and Nutrition Examination Survey.
    Mannino DM; Homa DM; Matte T; Hernandez-Avila M
    Nicotine Tob Res; 2005 Aug; 7(4):557-64. PubMed ID: 16085527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental lead exposure and cognitive function in community-dwelling older adults.
    Shih RA; Glass TA; Bandeen-Roche K; Carlson MC; Bolla KI; Todd AC; Schwartz BS
    Neurology; 2006 Nov; 67(9):1556-62. PubMed ID: 16971698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menopause transition stage and endogenous estradiol and follicle-stimulating hormone levels are not related to cognitive performance: cross-sectional results from the study of women's health across the nation (SWAN).
    Luetters C; Huang MH; Seeman T; Buckwalter G; Meyer PM; Avis NE; Sternfeld B; Johnston JM; Greendale GA
    J Womens Health (Larchmt); 2007 Apr; 16(3):331-44. PubMed ID: 17439378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-level lead exposure and the prevalence of gout: an observational study.
    Krishnan E; Lingala B; Bhalla V
    Ann Intern Med; 2012 Aug; 157(4):233-41. PubMed ID: 22910934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update: blood lead levels--United States, 1991-1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Feb; 46(7):141-6. PubMed ID: 9072671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lead exposure biomarkers and mini-mental status exam scores in older men.
    Wright RO; Tsaih SW; Schwartz J; Spiro A; McDonald K; Weiss ST; Hu H
    Epidemiology; 2003 Nov; 14(6):713-8. PubMed ID: 14569188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Vision Loss With Cognition in Older Adults.
    Chen SP; Bhattacharya J; Pershing S
    JAMA Ophthalmol; 2017 Sep; 135(9):963-970. PubMed ID: 28817745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III).
    Hailpern SM; Melamed ML; Cohen HW; Hostetter TH
    J Am Soc Nephrol; 2007 Jul; 18(7):2205-13. PubMed ID: 17554148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study.
    Komulainen P; Pedersen M; Hänninen T; Bruunsgaard H; Lakka TA; Kivipelto M; Hassinen M; Rauramaa TH; Pedersen BK; Rauramaa R
    Neurobiol Learn Mem; 2008 Nov; 90(4):596-603. PubMed ID: 18707012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort.
    Kanaya AM; Barrett-Connor E; Gildengorin G; Yaffe K
    Arch Intern Med; 2004 Jun; 164(12):1327-33. PubMed ID: 15226167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral health and cognitive function in the Third National Health and Nutrition Examination Survey (NHANES III).
    Stewart R; Sabbah W; Tsakos G; D'Aiuto F; Watt RG
    Psychosom Med; 2008 Oct; 70(8):936-41. PubMed ID: 18842752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between cognitive function and periodontal disease in older adults.
    Yu YH; Kuo HK
    J Am Geriatr Soc; 2008 Sep; 56(9):1693-7. PubMed ID: 18691281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between cognitive function, blood lead concentration, and nutrition among children in the central Philippines.
    Solon O; Riddell TJ; Quimbo SA; Butrick E; Aylward GP; Lou Bacate M; Peabody JW
    J Pediatr; 2008 Feb; 152(2):237-43. PubMed ID: 18206696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood lead levels in young children--United States and selected states, 1996-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Dec; 49(50):1133-7. PubMed ID: 11190117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure and cognitive impairment in India and the United States: a cross-national epidemiological study.
    Pandav R; Dodge HH; DeKosky ST; Ganguli M
    Arch Neurol; 2003 Aug; 60(8):1123-8. PubMed ID: 12925370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.